V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013276 | 160015609 | 1.76 | 51.8 | Palliative (P) | 2016-09-05 | 2016-09-10 | Carboplatin + Paclitaxel (3 weekly) | N | N | DOXORUBICIN + OLARATUMAB | 101588323 |
| 160013281 | 160015610 | 1.83 | 82 | Palliative (P) | 2020-04-08 | 2020-04-29 | Bevacizumab | 02 | N | CARBOPLATIN | 100472229 |
| 160013285 | 160015611 | 1.74 | 88.6 | Palliative (P) | 2019-09-02 | 2019-09-03 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + GEMCITABINE | 101219911 |
| 160013287 | 160015612 | 1.8 | 67.4 | Palliative (P) | null | 2021-02-25 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 101247750 |
| 160013293 | 160015613 | 1.66 | 72 | Neo-adjuvant (N) | 2018-10-11 | 2018-10-23 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100545890 |
| 160013294 | 160015614 | 1.73 | 60.8 | 03 | 2017-09-04 | 2017-09-06 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100675949 |
| 160013297 | 160015615 | 1.75 | 85.9 | Palliative (P) | 2017-11-17 | 2017-11-19 | Paclitaxel 7 day | N | N | PACLITAXEL | 101126733 |
| 160013301 | 160015616 | 1.74 | 60.5 | 03 | 2019-03-03 | 2019-03-03 | PACLITAXEL | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101445911 |
| 160013309 | 160015617 | 1.56 | 94.7 | Palliative (P) | 2020-04-16 | 2020-04-29 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100370378 |
| 160013316 | 160015618 | 1.74 | 99 | Palliative (P) | 2018-08-11 | 2018-08-26 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101205907 |
| 160013318 | 160015619 | null | 46 | Palliative (P) | 2020-02-25 | 2020-02-25 | Bevacizumab | N | N | CISPLATIN + PEMETREXED | 100555808 |
| 160013320 | 160015620 | 1.89 | 55.4 | Palliative (P) | 2020-03-21 | 2020-03-25 | Liposomal Doxorubicin 50mg/m2 | N | N | LIPOSOMAL DOXORUBICIN | 101426540 |
| 160013322 | 160015621 | 1.68 | 94 | Palliative (P) | 2019-03-15 | 2019-12-11 | Liposomal Doxorubicin 50mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100926441 |
| 160013332 | 160015622 | 1.74 | 80.6 | null | 2016-03-25 | 2020-12-07 | Bevacizumab | 02 | null | CARBOPLATIN + PACLITAXEL | 100642119 |
| 160013338 | 160015623 | 1.79 | 102.5 | Neo-adjuvant (N) | null | 2022-05-11 | Bevacizumab 7.5mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 101018061 |
| 160013339 | 160015624 | 1.7 | 54.8 | null | 2019-05-05 | 2019-05-29 | DOCETAXEL + GEMCITABINE | 02 | null | DOCETAXEL + GEMCITABINE | 101060229 |
| 160013340 | 160015625 | 1.79 | 70 | Palliative (P) | 2020-07-30 | 2020-08-15 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN | 100897656 |
| 160013342 | 160015626 | 1.79 | 83.4 | Neo-adjuvant (N) | null | 2021-09-17 | Bevacizumab 7.5mg/kg | 2 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101817793 |
| 160013344 | 160015627 | 1.68 | 59.2 | Palliative (P) | 2015-09-12 | 2019-06-28 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101474184 |
| 160013345 | 160015628 | 1.82 | 119.2 | null | 2020-12-26 | 2020-12-26 | Doxorubicin + Olaratumab | 02 | null | DOXORUBICIN + OLARATUMAB | 100698434 |
| 160013353 | 160015629 | 1.78 | 80.45 | Palliative (P) | 2020-01-26 | 2020-02-07 | Liposomal Doxorubicin 50mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100224197 |
| 160013357 | 160015630 | 1.89 | 77.9 | Palliative (P) | 2018-05-08 | 2018-05-23 | Liposomal Doxorubicin (Myocet) | 02 | N | LIPOSOMAL DOXORUBICIN | 101067983 |
| 160013359 | 160015631 | 1.76 | 99 | null | 2020-08-28 | 2020-10-06 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + PACLITAXEL | 101005052 |
| 160013365 | 160015632 | 1.69 | 80 | Palliative (P) | 2018-05-24 | 2018-07-06 | Liposomal Doxorubicin 50mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100523332 |
| 160013372 | 160015633 | 1.73 | 125 | Palliative (P) | null | 2021-02-18 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101726089 |
| 160013374 | 160015634 | 1.8 | 92.45 | null | 2016-02-04 | 2016-05-14 | Bevacizumab | 02 | null | CISPLATIN + PEMETREXED | 100159492 |
| 160013375 | 160015635 | 1.6 | 86.4 | Palliative (P) | 2017-07-19 | 2017-08-04 | Bevacizumab 7.5mg/kg | null | null | CARBOPLATIN + GEMCITABINE | 101181422 |
| 160013379 | 160015636 | 1.7 | 83 | Palliative (P) | 2021-07-17 | 2021-08-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100401618 |
| 160013389 | 160015637 | 1.64 | 67.2 | null | null | 2016-10-04 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101833545 |
| 160013391 | 160015638 | 1.86 | 68.85 | null | null | 2017-08-10 | Bevacizumab 15mg/kg | 02 | null | DOCETAXEL + GEMCITABINE | 100657827 |
| 160013394 | 160015639 | 1.67 | 71.55 | Palliative (P) | 2017-07-14 | 2017-11-03 | Bevacizumab | 02 | N | PACLITAXEL | 100193155 |
| 160013402 | 160015640 | 1.5 | 110.6 | null | 2016-12-25 | 2017-01-07 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + GEMCITABINE | 101472333 |
| 160013407 | 160015641 | 1.75 | 71.5 | null | null | 2019-04-13 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101212077 |
| 160013408 | 160015642 | 1.6 | 82.7 | Palliative (P) | 2020-08-31 | 2020-09-09 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 101393182 |
| 160013409 | 160015643 | 1.69 | 83.5 | Palliative (P) | null | 2018-09-19 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 100716809 |
| 160013414 | 160015644 | 1.66 | 95 | Palliative (P) | 2018-10-08 | 2018-11-27 | Bevacizumab | 02 | N | CARBOPLATIN + GEMCITABINE | 100000701 |
| 160013415 | 160015645 | 1.91 | 54 | Neo-adjuvant (N) | 2021-11-01 | 2021-11-01 | LIPOSOMAL DOXORUBICIN | N | N | LIPOSOMAL DOXORUBICIN | 101401710 |
| 160013420 | 160015646 | 1.83 | 72.6 | Palliative (P) | 2018-10-10 | 2018-11-17 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100363637 |
| 160013422 | 160015647 | 1.76 | 77 | Curative (C) | 2019-03-13 | 2020-05-18 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100232852 |
| 160013433 | 160015648 | 1.73 | 97 | null | 2018-12-06 | 2019-05-16 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100346681 |
| 160013440 | 160015649 | 1.54 | 68.4 | Palliative (P) | 2018-03-08 | 2018-03-08 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 101808874 |
| 160013444 | 160015650 | 1.65 | 94.1 | 03 | 2019-12-16 | 2020-01-13 | Bevacizumab | N | N | CISPLATIN + PEMETREXED | 101333690 |
| 160013452 | 160015651 | 1.83 | 100 | Palliative (P) | 2019-07-13 | 2019-08-10 | Docetaxel + Gemcitabine (prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 100000507 |
| 160013453 | 160015652 | 1.75 | 86.4 | Adjuvant (A) | 2020-12-31 | 2020-12-31 | Bevacizumab | N | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100513473 |
| 160013460 | 160015653 | 1.83 | 64.6 | Palliative (P) | 2019-11-08 | 2020-12-14 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100364850 |
| 160013463 | 160015654 | 1.62 | null | Palliative (P) | 2017-09-06 | 2018-03-18 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101114092 |
| 160013471 | 160015655 | 1.72 | 96 | Curative (C) | 2020-12-05 | 2020-12-24 | Bevacizumab | 02 | N | CARBOPLATIN + PACLITAXEL | 101145327 |
| 160013472 | 160015656 | 1.77 | 74.9 | Palliative (P) | 2022-02-07 | 2022-02-08 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101351770 |
| 160013477 | 160015657 | 1.44 | 80 | Palliative (P) | null | 2018-12-07 | PACLITAXEL | 02 | null | BEVACIZUMAB | 100846649 |
| 160013482 | 160015658 | 1.7 | 74 | Palliative (P) | 2018-09-12 | 2018-09-26 | GEMCARBO | 02 | N | CARBOPLATIN + GEMCITABINE | 101091689 |